Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

被引:117
作者
Heinemann, L [1 ]
Weyer, C [1 ]
Rauhaus, M [1 ]
Heinrichs, S [1 ]
Heise, T [1 ]
机构
[1] Univ Dusseldorf, Dept Metab Dis & Nutr, WHO, Collaborating Ctr Diabet, D-40001 Dusseldorf, Germany
关键词
D O I
10.2337/diacare.21.11.1910
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To study the intra- and interindividual variability of the metabolic activity of soluble insulin and of the rapid-acting insulin analog insulin aspart after subcutaneous injection. RESEARCH DESIGN AND METHODS - A total of nine healthy male volunteers received subcutaneous injections of soluble insulin (0.2 U/kg) in the abdominal region on each of the four study days. Another 10 volunteers received an injection of insulin aspart four times. Glucose infusion rates necessary to neutralize the blood glucose-lowering effect of the administered insulin were registered during euglycemic glucose clamps (blood glucose 5.0 mmol/l; basal intraveneous insulin infusion 0.15 mU.kg(-1).min(-1)) over the subsequent 600 min. We investigated the variation in metabolic activity by calculating coefficients of variation (CVs). RESULTS - In comparison to soluble insulin, subcutaneous injections of insulin aspart led to a more rapid onset of action and a shorter duration of action. Subcutaneous injection of the insulin preparations resulted in intraindividual CVs of the summary measures between 10 and 30% (soluble insulin vs. insulin aspart: maximal metabolic activity 15 +/- 7 vs. 16 +/- 10%, time to maximal metabolic activity 14 +/- 10 vs. 11 +/- 6%; NS between the preparations [means +/- SD]). The decline to half-maximal activity after maximal activity showed a lower intraindividual CV with insulin aspart (19 +/- 9 vs. 11 +/- 5%; P = 0.018). The interindividual CVs were higher than the intraindividual CVs (26 vs. 28, 23 vs. 19, and 26 vs. 17%). Generally, the pharmacodynamic variability was higher than the pharmacokinetic variability. For the pharmacokinetic measures, the intra- and interindividual variability in t(max) was lower for insulin aspart than for soluble insulin. CONCLUSIONS - The metabolic effect of soluble insulin shows an intraindividual variability of 10-20% in healthy volunteers, even under strictly controlled experimental conditions. The overall variability of action of insulin aspart was comparable to that of soluble insulin.
引用
收藏
页码:1910 / 1914
页数:5
相关论文
共 20 条
[1]  
ANTSIFEROV M, 1995, DIABETOLOGIA, V38, pA190
[2]   FITTING NONLINEAR-REGRESSION MODELS WITH CORRELATED ERRORS TO INDIVIDUAL PHARMACODYNAMIC DATA USING SAS SOFTWARE [J].
BENDER, R ;
HEINEMANN, L .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (01) :87-100
[3]  
BINDER C, 1969, ACTA PHARMACOL TOX, VS 27, P1
[4]   INSULIN PHARMACOKINETICS [J].
BINDER, C ;
LAURITZEN, T ;
FABER, O ;
PRAMMING, S .
DIABETES CARE, 1984, 7 (02) :188-199
[5]   Measurement error [J].
Bland, JM ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 1996, 312 (7047) :1654-1654
[6]   MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS [J].
BRANGE, J ;
OWENS, DR ;
KANG, S ;
VOLUND, A .
DIABETES CARE, 1990, 13 (09) :923-954
[7]  
DEMEIJER PHEM, 1990, DIABETIC MED, V7, P499
[8]   FACTORS INFLUENCING THE ABSORPTION, SERUM-INSULIN CONCENTRATION, AND BLOOD-GLUCOSE RESPONSES AFTER INJECTIONS OF REGULAR INSULIN AND VARIOUS INSULIN MIXTURES [J].
GALLOWAY, JA ;
SPRADLIN, CT ;
NELSON, RL ;
WENTWORTH, SM ;
DAVIDSON, JA ;
SWARNER, JL .
DIABETES CARE, 1981, 4 (03) :366-376
[9]  
Galloway T.A., 1986, DIABETES 1985, P877
[10]  
Heinemann L, 1996, DIABETIC MED, V13, P683, DOI 10.1002/(SICI)1096-9136(199607)13:7<683::AID-DIA144>3.0.CO